Review article · 2024 · Open access
Targeting CCR5: A central approach to HIV treatment and cure strategies
Virology, 603, 110375 · Published 24 December 2024 · DOI 10.1016/j.virol.2024.110375
In brief
“Targeting CCR5: A central approach to HIV treatment and cure strategies” is a 2024 review article by Yunus Yükselten and 3 co-authors, published in Virology. OpenAlex counts 19 citations as of 19 November 2026, which puts it in the top 3% of works published in 2024 by citations. It is open access: the full text is free to read at Virology.
- Citations
- 19
- Most cited in
- 2026 (13)
- Field-weighted impact
- 0.82
- References
- 122
- Authors
- 4
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Yükselten, Y., Wishah, H., Li, J. A., & Sutton, R. E. (2024). Targeting CCR5: A central approach to HIV treatment and cure strategies. Virology, 603, 110375. https://doi.org/10.1016/j.virol.2024.110375
MLA 9
Yükselten, Yunus, et al. “Targeting CCR5: A central approach to HIV treatment and cure strategies.” Virology, vol. 603, 2024, p. 110375. https://doi.org/10.1016/j.virol.2024.110375.
Chicago
Yükselten, Yunus, Hanan Wishah, Jessica A Li, and Richard E. Sutton. 2024. “Targeting CCR5: A central approach to HIV treatment and cure strategies.” Virology 603: 110375. https://doi.org/10.1016/j.virol.2024.110375.
Harvard
Yükselten, Y. et al. (2024) ‘Targeting CCR5: A central approach to HIV treatment and cure strategies’, Virology, 603, p. 110375. doi:10.1016/j.virol.2024.110375.
IEEE
Y. Yükselten, H. Wishah, J. A. Li, and R. E. Sutton, “Targeting CCR5: A central approach to HIV treatment and cure strategies,” Virology, vol. 603, p. 110375, 2024, doi: 10.1016/j.virol.2024.110375.
BibTeX
@article{yukselten2024targeting,
title = {{Targeting CCR5: A central approach to HIV treatment and cure strategies}},
author = {Yükselten, Yunus and Wishah, Hanan and Li, Jessica A and Sutton, Richard E.},
journal = {Virology},
year = {2024},
volume = {603},
pages = {110375},
doi = {10.1016/j.virol.2024.110375},
url = {https://doi.org/10.1016/j.virol.2024.110375}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- CCR5
- HIV infection
- CCR5 delta32 mutation
- HIV co-receptor
- genome editing
- monoclonal antibodies
- post-transcriptional regulation
- functional cure
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Yükselten, Y., Wishah, H., Li, J. A., & Sutton, R. E. (2024). Targeting CCR5: A central approach to HIV treatment and cure strategies. Virology, 603, 110375. https://doi.org/10.1016/j.virol.2024.110375
How many times has this paper been cited?
19 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Virology: sign in and open the full text from this page.
Who wrote this paper?
Yunus Yükselten, Hanan Wishah, Jessica A Li, Richard E. Sutton.
What is the DOI of this paper?
10.1016/j.virol.2024.110375, permanently at https://doi.org/10.1016/j.virol.2024.110375. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.